← Open Payments lookup

ROBERT EARLE: Open Payments

NPI 1750506986 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$470 in 22 payments from 9 companies in 2025. Trend: 2023 $726 · 2024 $311 · 2025 $470

Food & beverage: $470
CompanyPaymentsAmount
Axsome Therapeutics, Inc.8$138
Otsuka America Pharmaceutical, Inc.3$78
Neurocrine BioSciences, Inc.3$74
E.R. Squibb & Sons, L.L.C.2$62
ABBVIE INC.2$43
Takeda Pharmaceuticals U.S.A., Inc.1$22
Vanda Pharmaceuticals Inc.1$19
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Janssen Pharmaceuticals, Inc1$16

Products named: Auvelity, REXULTI, INGREZZA, COBENFY, VRAYLAR, TRINTELLIX, FANAPT, CAPLYTA.

Industry payments across TX — which companies pay providers there.